CD69 and B-cell chronic lymphocytic leukemia: In keeping with observations in patients, we found that xenografted CLL cells in the murine spleen as compared to matched PB samples showed significantly increased expression of the activation markers CD38 and CD69 (Figure 2a-b, P = .03 and P < .001, respectively).